Theiler’s virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains

• Published in: Cellular Immunology 2006, Vol.239 (1), p.31-40
• Main Authors: Rubio, Nazario, Sanz-Rodriguez, Francisco, Lipton, Howard L.
• Format: Article
• Language: English
• Subjects: Animals; Antibodies - immunology; Astrocytes; Astrocytes - cytology; Astrocytes - immunology; Astrocytes - metabolism; Astrocytes - secretion; Cardiovirus Infections - genetics; Cardiovirus Infections - virology; CD11b Antigen - metabolism; CD3 Complex - metabolism; Cells, Cultured; Chemokine CXCL2; Chemokines; Chemotactic Factors - immunology; Chemotactic Factors - metabolism; Chemotaxis - drug effects; Cricetinae; Culture Media - pharmacology; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation; Genetic Predisposition to Disease; Mice; Monokines - genetics; Monokines - immunology; Monokines - metabolism; Monokines - secretion; Multiple sclerosis; Neutrophils; RNA, Messenger - genetics; RNA, Messenger - metabolism; Theiler's encephalomyelitis virus; Theilovirus - physiology
• ISSN: 0008-8749; 1090-2163; 1365-2567
• DOI: 10.1016/j.cellimm.2006.03.003

The murine encephalomyelitis virus of Theiler (TMEV) induces demyelination in susceptible strains of mice by a CD4 + Th1 T cell mediated immunopathologic process. We focused on the production of one chemokine, the macrophage inflammatory protein-2 (MIP-2 or CXCL2), by cultured mouse astrocytes infected with the BeAn strain of TMEV. Analysis of a murine genome DNA hybridized with cRNA from mock- and TMEV-infected astrocytes, revealed up-regulation of three sequences encoding MIP-2. Northern blot analysis indicated increased MIP-2 mRNA expression. Levels of MIP-2 in the supernatants of infected cells as detected by ELISA, varied directly with the multiplicity of infection used. This secreted CXCL2 was biologically active inducing chemoattraction of neutrophils but not of lymphocytes. CXCL2 was specifically induced by TMEV infection, since induction was inhibited by anti TMEV antibodies. The inflammatory cytokines, IL-1α and TNF-α, which are also induced in astrocytes by TMEV, were very potent inducers of CXCL2. Nevertheless, both mechanisms of induction follows different pathways as antibodies to both cytokines fails to inhibit TMEV-induced CXCL2 up-regulation. Sera from TMEV-infected SJL/J mice with chronic demyelination, but not from BALB/c TMEV-resistant mice, revealed CXCL2 at the peak of clinical disease. Our main novel finding is the strain-dependent differences in CXCL2 expression both in vitro and in vivo. This suggest an role for this chemokine in attracting immune cells within the CNS, which in turn, might trigger demyelination in this experimental model of MS.